Abbott

The UCSF Viral Diagnostics and Discovery Center, located near the school's Mission Bay, Calif., campus, will use the ViroChip pathogen-identification and screening tool as its "core technology."

The UCSF Viral Diagnostics and Discovery Center will use sequencing, microarrays, and other genomic technologies to characterize pathogens linked to acute and chronic human illnesses.

The suit revolves around patents owned by UNeMed, the technology-transfer organization for the UN Medical Center, and exclusively licensed to Abbot Laboratories, though Abbott is not listed as a co-plaintiff on the complaint.

The California District court denied motions for summary judgment of invalidity of Abbott's in situ DNA hybridization patent.

LGC will develop clinical and non-clinical applications for the Ibis T5000 Biosensor System.

Snippets

Premium

Epigenomics, Response Genetics, Exact Sciences

People in the News

Premium

Shaun Lonergan

Paired Ends

Premium

Kevin Ulmer, Patrick Soon-Shiong, Shaun Lonergan

People in the News

William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.

Pages

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.